NativeMed review

The opening bill and recurring rate are different

NativeMed is worth comparing for self-pay access when the actual plan is kept intact. Its semaglutide three-month selection shows $149 per month with $447 paid upfront. Switching to Monthly shows a $159 first month and $179 per month thereafter. The headline equivalent is therefore not the price of trying the service for one month. Start the comparison with the amount charged and the rate that follows. ^[1]

Tirzepatide has its own figures: $183 per month with $549 upfront for three months, or a monthly selection showing $199 first and $259 per month thereafter. Do not apply the semaglutide rate or introductory condition to that separate prescription. The page advertises the same price at any dose, but the provider still decides the prescribed preparation and amount. ^[2]

Separate the initial charge from the recurring bill in the complete GLP-1 cost planner.

The cancellation FAQ is not the refund agreement

The homepage says there are no long-term contracts or cancellation fees and describes responsibility for medication already shipped. The refund policy is narrower: program payments are generally nonrefundable, with a weight-loss exception requested within twenty-four hours of purchase before medication has shipped. An administrative cancellation fee applies, but its amount is not stated there. Get that condition settled before treating the service as a risk-free trial. ^{[3] [4]}

The separate weight-loss contract describes an initially free virtual consultation but says a $25 fee may apply if the person chooses not to proceed on the call. It also lists a $25 late-cancellation or no-show fee for cancelling within two hours or missing the appointment, and separately charged maintenance calls. Those are different charges from the unquoted refund administration fee; do not silently assign the same amount to all of them. ^[5]

Compare another larger-supply commitment in our PeptidesRx supply-and-refund review.

For a different renewal agreement and a longer conditional guarantee, read our ReadyRx renewal-and-guarantee review.

Know which professional is responsible for the next step

NativeMed facilitates access rather than practicing medicine or dispensing the prescription itself. Its pharmacy policy lists VialsRx as a possible partner and says the actual dispenser is identified on the label or pharmacy documentation. Fulfillment depends on the prescription, state and availability. A partner listing does not guarantee that every selected product is filled by that pharmacy. ^[6]

The policy routes treatment concerns to the provider, formulation and storage questions to the dispensing pharmacy, and order questions to NativeMed support. That is a useful division if the buyer can reach those contacts. The website’s ongoing-support language does not establish an immediate clinician response or a fixed appointment calendar. Confirm the follow-up and the complete selected bill rather than infer either from a fast-approval headline. ^{[3] [6]}

For a different clinical-contact and renewal agreement, read our RNK care-and-renewal review.

Compare the preparation before the headline saving

The advertised medications are compounded preparations, not FDA-approved generic equivalents of a branded product. FDA does not review compounded drugs for safety, effectiveness and quality before marketing. A trial result for a specified approved product cannot automatically be transferred to every preparation sharing its ingredient name. That distinction remains even when the price, delivery and portal are convenient. ^{[6] [7]}

Choose NativeMed if the selected prescription, care arrangement and real continuing cost fit the need. If insurance navigation or a branded pathway is the priority, compare a service organized around that task. If the main attraction is the three-month equivalent, first settle the upfront payment, consultation conditions and narrow refund window. A cheaper-looking monthly label should not do the work of the agreement.

For another care and product-access model, compare our clinic-versus-pharmacy-access comparison.

Understanding the cost

Semaglutide monthly selection: first month $159, then $179/month; three-month option $149/month with $447 paid upfront. Tirzepatide monthly: first month $199, then $259/month; three-month option $183/month with $549 upfront. Weight-loss terms describe possible $25 consultation-related fees and separately charged maintenance calls.